Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Insulin receptor substrate signaling suppresses neonatal autophagy in the heart
Christian Riehle, … , Morris F. White, E. Dale Abel
Christian Riehle, … , Morris F. White, E. Dale Abel
Published November 1, 2013
Citation Information: J Clin Invest. 2013;123(12):5319-5333. https://doi.org/10.1172/JCI71171.
View: Text | PDF
Research Article Cardiology

Insulin receptor substrate signaling suppresses neonatal autophagy in the heart

  • Text
  • PDF
Abstract

The induction of autophagy in the mammalian heart during the perinatal period is an essential adaptation required to survive early neonatal starvation; however, the mechanisms that mediate autophagy suppression once feeding is established are not known. Insulin signaling in the heart is transduced via insulin and IGF-1 receptors (IGF-1Rs). We disrupted insulin and IGF-1R signaling by generating mice with combined cardiomyocyte-specific deletion of Irs1 and Irs2. Here we show that loss of IRS signaling prevented the physiological suppression of autophagy that normally parallels the postnatal increase in circulating insulin. This resulted in unrestrained autophagy in cardiomyocytes, which contributed to myocyte loss, heart failure, and premature death. This process was ameliorated either by activation of mTOR with aa supplementation or by genetic suppression of autophagic activation. Loss of IRS1 and IRS2 signaling also increased apoptosis and precipitated mitochondrial dysfunction, which were not reduced when autophagic flux was normalized. Together, these data indicate that in addition to prosurvival signaling, insulin action in early life mediates the physiological postnatal suppression of autophagy, thereby linking nutrient sensing to postnatal cardiac development.

Authors

Christian Riehle, Adam R. Wende, Sandra Sena, Karla Maria Pires, Renata Oliveira Pereira, Yi Zhu, Heiko Bugger, Deborah Frank, Jack Bevins, Dong Chen, Cynthia N. Perry, Xiaocheng C. Dong, Steven Valdez, Monika Rech, Xiaoming Sheng, Bart C. Weimer, Roberta A. Gottlieb, Morris F. White, E. Dale Abel

×

Figure 2

Mitochondrial dysfunction precedes age-dependent contractile dysfunction in CIRS12KO hearts.

Options: View larger image (or click on image) Download as PowerPoint
Mitochondrial dysfunction precedes age-dependent contractile dysfunction...
(A) Representative immunoblots for IRS1 and IRS2 in ventricle homogenates obtained from 1-day-old mice. (B) H&E stains of 2 chamber sections and higher-magnification views of ventricle sections at 1 day of age. Scale bars: 500 μm (top); 10 μm (bottom). (C and D) Representative M-mode images showing normal contractile function in CIRS12KO mice (C) and mRNA expression of heart failure/hypertrophy markers (D) at 1 day of age. (E) Diminished phosphorylation of IRS1/IRS2 downstream targets in 1-day-old CIRS12KO hearts. (F) Survival curves. (G) Time course for FS and LVDs (n = 4–15). (H) Age-dependent repression of mRNAs encoding genes involved in FAO and glucose oxidation, OXPHOS, and their transcriptional regulators in CIRS12KO hearts (n = 6–8). Data are presented as fold change compared with same-age WT (assigned as 1.0; dashed line) and normalized to Cphn (1 day and 4 weeks) or Lama1 (2 weeks). (I) VADP and ATP production in cardiac fibers from 2-week-old CIRS12KO mice with succinate (Suc) as substrate plus rotenone (n = 6). dw, dry weight. (J) VADP respiration and ATP synthesis with pyruvate (Pyr), palmitoyl-carnitine (PC), or glutamate (Glu), each combined with malate as substrate in fibers obtained at 4 weeks of age (n = 6). *P < 0.05 vs. WT same age, unpaired Student’s t test. See Supplemental Table 11 for gene names.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts